Holen Sie sich die Stockscreener-App
80.95
0.24%
0.19
Handel nachbörslich:
80.11
-0.84
-1.04%
Schlusskurs vom Vortag:
$80.76
Offen:
$80
24-Stunden-Volumen:
209.96K
Relative Volume:
2.80
Marktkapitalisierung:
$499.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.12M
KGV:
-35.20
EPS:
-2.3
Netto-Cashflow:
$-6.82M
1W Leistung:
-6.05%
1M Leistung:
-17.83%
6M Leistung:
+107.03%
1J Leistung:
+414.62%
1-Tages-Spanne:
$77.82
$83.86
1-Wochen-Bereich:
$77.00
$86.16
52-Wochen-Spanne:
$15.50
$105.00
Monopar Therapeutics Inc Stock (MNPR) Company Profile
Firmenname
Monopar Therapeutics Inc
Sektor
Branche
Telefon
(847) 388-0349
Adresse
1000 SKOKIE BLVD SUITE 350, WILMETTE
Vergleichen Sie MNPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
80.95 | 498.29M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-13 | Eingeleitet | Barclays | Overweight |
| 2025-09-09 | Eingeleitet | BTIG Research | Buy |
| 2025-09-03 | Eingeleitet | Oppenheimer | Outperform |
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-08-26 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-19 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-10 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-11 | Eingeleitet | Rodman & Renshaw | Buy |
| 2021-01-28 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Monopar Therapeutics Inc Aktie (MNPR) Neueste Nachrichten
Monopar Therapeutics announces pricing of $40M public offering of common stock - MSN
How Monopar Therapeutics Inc. (1IY0) stock correlates with oil marketsQuarterly Profit Review & Low Drawdown Investment Ideas - newser.com
Why Monopar Therapeutics Inc. stock attracts global investorsDip Buying & Verified Momentum Stock Watchlist - newser.com
What moving averages say about Monopar Therapeutics Inc.July 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
How Monopar Therapeutics Inc. (1IY0) stock reacts to monetary easing2025 EndofYear Setup & Technical Pattern Based Signals - newser.com
Top chart patterns to watch in Monopar Therapeutics Inc.2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
Monopar Therapeutics Inc. stock prediction for this weekMarket Activity Summary & Community Consensus Stock Picks - newser.com
Is Monopar Therapeutics Inc. stock entering bullish territoryJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
Will Monopar Therapeutics Inc. stock deliver long term returnsTreasury Yields & Free Real-Time Volume Trigger Notifications - newser.com
Exit strategy if you’re trapped in Monopar Therapeutics Inc.July 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Is Monopar Therapeutics Inc. forming a reversal patternTrade Analysis Report & Weekly Momentum Picks - newser.com
Heatmap analysis for Monopar Therapeutics Inc. and competitorsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
Applying sector rotation models to Monopar Therapeutics Inc.2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
Why Monopar Therapeutics Inc. stock remains a top recommendationJuly 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - newser.com
Is Monopar Therapeutics Inc. stock attractive for retirement portfoliosWall Street Watch & Verified Trade Idea Suggestions - newser.com
Monopar Therapeutics Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView
When is the best time to exit Monopar Therapeutics Inc.2025 Stock Rankings & Daily Momentum Trading Reports - newser.com
Has Monopar Therapeutics Inc. formed a bullish divergenceWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com
Multi factor analysis applied to Monopar Therapeutics Inc.Wall Street Watch & Risk Managed Investment Signals - newser.com
Monopar Therapeutics (NASDAQ:MNPR) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.44%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):